Research summary
Research summary
08/22/2024
In a multicenter, retrospective study, researchers evaluated time from NMOSD onset to serological diagnosis and factors associated with predicting shorter time to diagnosis.
08/22/2024
Research summary
Research summary
07/23/2024
A team of researchers sought to determine the prevalence of depression and anxiety in patients with NMOSD before their diagnosis of the disease.
07/23/2024
Research Summary
Research Summary
06/11/2024

Anthony Calabro, MA

Anthony Calabro, MA
A systematic review and meta-analysis examined the clinical differences between adult patients with neuromyelitis optica spectrum disorders and those with multiple sclerosis.
06/11/2024
RESEARCH SUMMARY
RESEARCH SUMMARY
05/20/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers set out to determine whether renal function could be used as both a predictor of relapse risk for patients with their first onset of aquaporin-4 (AQP4)-immunoglobulin G (IgG)-seropositive...
05/20/2024
FDA
FDA
08/17/2020
The US Food and Drug Administration has approved a new treatment for neuromyelitis optica spectrum disorder among adults with the AQP4 antibody.
08/17/2020
Pediatrics
Pediatrics
03/13/2020
Researchers investigated the entire spectrum of myelin oligodendrocyte glycoprotein antibody-associated syndromes in children. The frequency, distribution, and treatment response of the syndromes were...
03/13/2020
vaccination
vaccination
10/27/2017
In a recent study, researchers investigated the association between vaccination and the risk of relapse in patients with neuromyelitis optica spectrum disorder, and the effects of immunosuppressive therapy...
10/27/2017